The role of aldosteronism in causing obesity-related cardiovascular risk.

Cardiology Clinics
David A Calhoun, Kumar Sharma

Abstract

A large body of evidence strongly links aldosterone to development and progression of cardiovascular disease, including vascular stiffness, left ventricular hypertrophy, congestive heart failure, chronic kidney disease, and, especially, hypertension. Emerging data suggest that adipocytes may serve as a source of aldosterone, either directly or indirectly, through the release of aldosterone-stimulating factors. If adipocytes are confirmed to have an important contribution to hyperaldosteronism, it would have significant clinical implications in linking aldosterone to obesity-related increases in cardiovascular risk. Such a cause-and-effect situation would then provide the opportunity to reverse that risk with preferential use of aldosterone antagonists in obese patients.

References

Apr 1, 1994·Clinical and Experimental Pharmacology & Physiology·R D GordonJ C Rutherford
Sep 2, 1999·Prostaglandins, Leukotrienes, and Essential Fatty Acids·T L GoodfriendD E Kelley
Mar 29, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·B J GallayR C Davidson
Jun 19, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·G AndronicoG Cerasola
Dec 7, 2002·Hypertension·David A CalhounPaula Weissmann
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·Stefan EngeliArya M Sharma
Nov 14, 2003·Proceedings of the National Academy of Sciences of the United States of America·M Ehrhart-BornsteinS R Bornstein
Jan 14, 2004·Hypertension·Theodore L GoodfriendKasem Nithipatikom
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Erin E Kershaw, Jeffrey S Flier
Jan 5, 2005·Hypertension·Stefan EngeliArya M Sharma
Feb 9, 2005·Hypertension·Clarence E GrimTheodore A Kotchen
Jan 25, 2006·Hypertension·Ernesto L Schiffrin
Jun 21, 2006·Hypertension·Murielle BochudMichel Burnier
Jun 28, 2006·Hypertension·Gian Paolo RossiUNKNOWN PAPY Study Participants
Nov 16, 2006·The Journal of Biological Chemistry·Kenichi YokotaHiroshi Itoh
Aug 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Murray EpsteinBruce Beckerman
Jan 26, 2008·HIV Medicine·A NguyenUNKNOWN Swiss HIV Cohort Study
Aug 23, 2008·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·C Dall'AstaA E Pontiroli
Dec 6, 2008·Journal of Pharmacological Sciences·Hideyasu KiyomotoAkira Nishiyama
Dec 17, 2008·Journal of the American Society of Nephrology : JASN·Per SvenningsenOle Skøtt
Aug 28, 2009·American Journal of Physiology. Renal Physiology·Sun Ha LeeShin-Wook Kang
Sep 10, 2009·American Journal of Nephrology·Nitin KhoslaGeorge L Bakris
Oct 1, 2009·Journal of Peptide Science : an Official Publication of the European Peptide Society·Felix Weiland, Eugen J Verspohl
Oct 6, 2009·Trends in Endocrinology and Metabolism : TEM·Maria-Christina ZennaroBruno Fève
Oct 13, 2009·The Journal of Clinical Endocrinology and Metabolism·Samantha Alvarez-MadrazoJohn M Connell

❮ Previous
Next ❯

Citations

Jun 7, 2013·Journal of Human Hypertension·T Dudenbostel
May 15, 2013·European Heart Journal·Luminita H PojogaGail K Adler
Feb 4, 2016·Current Hypertension Reports·Andrea VecchiolaCarlos E Fardella
Sep 3, 2011·European Journal of Clinical Investigation·Theodora PappaGeorge Piaditis
Jul 1, 2016·Journal of Molecular Endocrinology·Aurelie Nguyen Dinh CatRhian M Touyz
Jun 3, 2016·The Journal of Endocrinology·Ding Xie, Wendy B Bollag
Apr 29, 2016·Therapeutic Advances in Cardiovascular Disease·Greicy Mara Mengue Feniman De StefanoLuis Cuadrado Martin
Jun 8, 2018·The Journal of Endocrinology·Clara LefrancAurelie Nguyen Dinh Cat
Dec 25, 2015·Journal of the American Heart Association·Alessia BuglioniJohn C Burnett
Jun 30, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Ana Paula DavelEric J Belin de Chantemèle
Feb 23, 2019·Health Care for Women International·Jianxia ZhaiBeverley Copnell
Feb 13, 2019·American Journal of Hypertension·Andrea VecchiolaCarlos Enrique Fardella
Jan 31, 2018·Nature Reviews. Nephrology·Katrina M Mirabito Colafella, Kate M Denton
Aug 30, 2020·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Daniela MedinaAmy C Arnold
Oct 26, 2018·Hypertension·Robert M CareyUNKNOWN American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension; Council
Sep 1, 2013·Hormone Molecular Biology and Clinical Investigation·Emmanuelle Kuhn, Marc Lombès
Dec 13, 2016·Heart Failure Reviews·Milla Marques HermidorffMauro César Isoldi
Aug 22, 2013·American Journal of Physiology. Endocrinology and Metabolism·Manjunath RamanjaneyaHarpal S Randeva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.